Amylyx Pharmaceuticals
AMLX
$33.75
-2.85%
AMLX
Amylyx Pharmaceuticals
$33.75
AMLX price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Amylyx Pharmaceuticals's 12-month outlook, with a consensus price target around $42.36 and implied upside of +25.5% versus the current price.
Average Target
$42.36
0 analysts
Implied Upside
+25.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$20 - $57
Analyst target range
Drowning in data?
Find the real signal!
AMLX Technical Analysis
Beta
-0.20
-0.20x market volatility
Max Drawdown
-30.6%
Largest decline past year
52-Week Range
$9-$41
Price range past year
Annual Return
+259.8%
Cumulative gain past year
| Period | AMLX Return | S&P 500 |
|---|---|---|
| 1m | +66.2% | +2.7% |
| 3m | +154.0% | +1.0% |
| 6m | +124.3% | +12.0% |
| 1y | +259.8% | +18.9% |
| ytd | +195.5% | +12.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is AMLX Overvalued?
PE
-7.9x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-6.4x
Enterprise Value Multiple
